Advanced Search

    Technical Analysis for HCWB - HCW Biologics Inc.

    Grade Last Price % Change Price Change
    D 1.35 4.65% 0.06
    HCWB closed up 4.65 percent on Wednesday, March 22, 2023, on 6 percent of normal volume.
    Earnings due: Mar 27
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical HCWB trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness 4.65%
    Wide Bands Range Expansion 4.65%
    Lower Bollinger Band Touch Weakness 4.65%
    Oversold Stochastic Weakness 4.65%
    New 52 Week Closing Low Bearish 20.54%
    180 Bearish Setup Bearish Swing Setup 20.54%
    Older End-of-Day Signals for HCWB ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 3% about 13 hours ago
    Down 2 % about 13 hours ago
    Down 1% about 13 hours ago
    Rose Above Previous Day's High 1 day ago
    Rose Above Lower Bollinger Band 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    HCW Biologics Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation and age-related diseases. The company is involved in developing HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. It is also developing HCW9218 as an injectable immunotherapeutic for patients with pancreatic, breast, ovarian, colorectal, and prostate cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Prostate Cancer Acute Myeloid Leukemia Immunotherapies Leukemia Pulmonary Fibrosis Oncogenes Treatment Of Acute Myeloid Leukemia Age Related Diseases Alopecia Areata

    Is HCWB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Feb 13 Bullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last year
    Jan 3 HCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year ago
    Dec 8 HCW Biologics Enters CRADA with National Cancer Institute
    Dec 7 HCW Biologics gets US patent linked to potential cancer drug
    Dec 7 HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform
    Nov 8 Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting
    Nov 7 HCW Biologics GAAP EPS of -$0.14, revenue of $1.8M
    Nov 7 HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights
    See more HCWB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.31
    52 Week Low 1.09
    Average Volume 24,214
    200-Day Moving Average 2.15
    50-Day Moving Average 1.84
    20-Day Moving Average 1.63
    10-Day Moving Average 1.44
    Average True Range 0.14
    RSI 34.64
    ADX 42.57
    +DI 11.28
    -DI 37.82
    Chandelier Exit (Long, 3 ATRs) 1.60
    Chandelier Exit (Short, 3 ATRs) 1.51
    Upper Bollinger Bands 2.11
    Lower Bollinger Band 1.14
    Percent B (%b) 0.22
    BandWidth 59.84
    MACD Line -0.17
    MACD Signal Line -0.13
    MACD Histogram -0.0411
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.55
    Resistance 3 (R3) 1.53 1.46 1.51
    Resistance 2 (R2) 1.46 1.41 1.46 1.50
    Resistance 1 (R1) 1.40 1.38 1.43 1.42 1.49
    Pivot Point 1.33 1.33 1.34 1.33 1.33
    Support 1 (S1) 1.27 1.28 1.30 1.29 1.21
    Support 2 (S2) 1.20 1.25 1.20 1.20
    Support 3 (S3) 1.14 1.20 1.19
    Support 4 (S4) 1.16